Login | Register

Alzheimer’s – Let’s Focus On Early Stages, FDA Proposes

In an effort to treat and identify Alzheimer's patients early on during the disease, the FDA says it may relax the guidelines on Alzheimer's early-stage trials. The Agency has issued a proposal designed to help researchers and developers find new treatments for patients before the onset of overt (noticeable) dementia...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *